Individual, healthcare professional and system-level barriers and facilitators to initiation and adherence to injectable therapies for type 2 diabetes: A systematic review and meta-ethnography.
Jo L ByrneAndrew WillisAlison J DunkleyClaire FitzpatrickSandra CampbellManbinder S SidhuPratik ChoudharyMelanie Jane DaviesKamlesh Khunti F MedSciPublished in: Diabetic medicine : a journal of the British Diabetic Association (2021)
The first synthesis of contemporary qualitative data to adopt an intersectionality approach and explore diverse views relating to barriers and facilitators that influence engagement with injectable treatments for type 2 diabetes. A model is presented to help patients, health practitioners and policy makers identify barriers and facilitators and understand the complex interplay of physical, psychological and social factors involved when prescribing injectable therapies. Despite advances in injectable treatments and guidelines, findings highlight the many barriers that still exist and show how strongly held culturally-specific health beliefs of people from diverse socio-economic and ethnic backgrounds can become substantial obstacles to treatment.
Keyphrases
- healthcare
- type diabetes
- mental health
- public health
- hyaluronic acid
- primary care
- end stage renal disease
- glycemic control
- tissue engineering
- health information
- ejection fraction
- newly diagnosed
- chronic kidney disease
- insulin resistance
- peritoneal dialysis
- physical activity
- prognostic factors
- emergency department
- systematic review
- metabolic syndrome
- clinical practice
- machine learning
- smoking cessation
- depressive symptoms
- weight loss
- affordable care act